Clinical Trials Logo

Clinical Trial Summary

In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue. The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure. This clinical trial aims to assess the clinical utility of magnetic resonance elastography (MRE), in evaluating the stiffness and adhesion of spinal cord tumors and guiding surgical planning to selecting the most appropriate surgical approach for patients with spinal cord tumors.


Clinical Trial Description

Spinal cord tumors are a common condition in neurosurgery, including neurofibroma, spinal meningioma, ependymoma, glioma, spinal lipoma, and so on. Magnetic resonance imaging (MRI) plays a crucial role in the preoperative evaluation and planning of spinal cord tumor surgery. It provides detailed information about the tumor's location, size, and relationship to adjacent structures. However, routine MRI may not always provide sufficient information about the tumor's stiffness or adhesion, which can impact surgical planning and postoperative outcomes. Magnetic resonance elastography and slip interface imaging can help measure the mechanical properties of tissues, including their stiffness or adhesion. By combining the above methods, surgeons can identify areas of potential tumor adherence or invasion into surrounding structures, allowing for more precise surgical resection and minimizing the risk of damage to critical neural tissue. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05957679
Study type Interventional
Source Shengjing Hospital
Contact Yu Shi, MD
Phone +86 189 4025 9980
Email 18940259980@163.com
Status Recruiting
Phase N/A
Start date January 1, 2023
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT00826241 - Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma Phase 2